Our results indicate that ET-1 may play a critical role in mediating myopathy and adipose inflammation through the release of IL-6, TNF-α, or adipokines visfatin through PI3K/Akt/miR-let-7g-5p pathways in elderly individuals with diabetes (Figure 9). Here, IL6 is linked to myopathy.